Somatic (Tumour) Genomic Testing
A cancer diagnosis raises countless questions, and understanding the genetic makeup of your specific tumour can shape everything that follows. Our Somatic Genomic Testing service analyses the DNA within your tumour cells, identifying the molecular drivers behind its growth to guide truly targeted, evidence-based treatment decisions.
Somatic Genomic Testing : Precision Cancer Guidance by UK Clinical Experts
In the modern oncology landscape, a cancer diagnosis is no longer just about the location of the tumour—it is about the genetic driver behind its growth. Somatic genomic testing (also known as tumour profiling) is the gold standard for identifying the specific DNA alterations that occur within cancer cells. This technology is at the forefront of The Future of Personalised Medicine , shifting the focus from general treatments to individualised care.
Unlike traditional pathology, our somatic testing at London Genetics reveals what the tumour is doing at a molecular level. This is a crucial component of modern Cancer Genetic Testing, providing deeper insights than standard diagnostic tools.
Precision Guidance for Personalised Treatment
The primary goal of our specialist-led somatic testing is to move away from the “one-size-fits-all” chemotherapy approach. By identifying targetable molecular alterations, we integrate Oncology Pharmacogenomics to provide your medical team with a roadmap to:
Identify Targeted Therapies: Matching your specific genetic mutations with FDA/EMA-approved drugs, a breakthrough explored in our guide on Targeted Cancer Therapy.
Predict Treatment Response: Understanding which treatments are likely to be effective, similar to how Pharmacogenomics helps in Personalised Drug Dosing.
Monitor Clonal Evolution: Tracking how a tumour’s genetic makeup changes over time to stay ahead of potential drug resistance.
The UK Clinical Advantage
Based in the heart of London’s medical district and affiliated with world-class institutions like University College London (genetic specialist), our model ensures that your data is reviewed by a GMC-registered expert. As detailed in the Introduction of Doctor, Dr. Ehsan Ghayoor Karimiani ensures that every Genetic Testing Result Interpretation is clinically actionable.
We don’t just deliver a report; we deliver clarity in the most complex moments of your healthcare journey.
The Genetic Fingerprint of Cancer
Beyond Diagnosis: Understanding the Genetic Fingerprint of Your Tumour
Cancer is a disease of the genome. While traditional oncology focuses on the organ of origin, precision medicine looks deeper into the Somatic Mutations—genetic changes that occur specifically within the tumour cells. These mutations act as a “genetic fingerprint,” unique to every patient’s cancer.
At London Genetics, we use advanced Genomic Tests to sequence this fingerprint. This process is distinct from Inherited Disorders Testing, as it identifies acquired alterations that drive tumour growth, rather than genes passed down through families.
Why “Tumour-Only” Sequencing is Just the Beginning
Understanding the somatic profile is the first step in Targeted Cancer Therapy. However, the true clinical challenge lies in distinguishing these acquired mutations from your background Genetic Risk Assessment.
By analysing the tumour’s genomic architecture, we can identify:
Driver Mutations: The “engines” that push the cancer to spread.
Passenger Mutations: Background changes that do not affect treatment.
Biomarkers for Immunotherapy: Indicators that tell us if your immune system can be trained to fight the tumour.
Who Should Consider Somatic Genomic Testing?
Somatic Genomic Testing is relevant at several different stages of a cancer journey, though it's particularly valuable in the following circumstances.
Testing shortly after diagnosis can provide crucial molecular insight before treatment even begins, helping your oncology team identify targeted therapies that may be more effective, and better tolerated, than a standard treatment approach alone.
This early molecular insight means treatment decisions can be shaped by your tumour's specific characteristics right from the start, rather than relying on a generic, one-size-fits-all protocol.
If a current treatment isn't working as expected, Somatic Genomic Testing can reveal why, sometimes identifying resistance mutations or previously undetected molecular targets, helping your medical team pivot towards a more effective strategy sooner rather than later.
For patients exploring advanced or emerging treatment options, testing can uncover rare molecular markers that may qualify them for specific clinical trials, both in the UK and internationally.
Identifying eligibility for these trials can open doors to treatments not yet widely available, giving patients access to options beyond conventional care pathways.
Whatever stage of your journey you're at, Somatic Genomic Testing offers genuine clarity on the molecular reality of your specific tumour, supporting more informed, targeted decisions at every step.
What’s Included in Your Consultation?
Somatic Genomic Testing generates a substantial amount of molecular data, but without expert clinical interpretation, this information alone can be overwhelming rather than useful. At London Genetics, every consultation focuses on translating complex genomic findings into clear, clinically meaningful guidance.
Identifying Actionable Variants
Not every mutation detected through Somatic Genomic Testing is relevant to treatment. Your specialist carefully distinguishes between “actionable” variants, those with a corresponding targeted therapy or clinical trial, and “passenger” mutations that have no bearing on your care, ensuring attention is focused where it genuinely matters.
Navigating Variants of Uncertain Significance (VUS)
Many reports include Variants of Uncertain Significance, genetic changes whose clinical impact isn’t yet fully understood. Rather than leaving these unexplained, your specialist cross-references the latest research and global databases to reassess their potential relevance to your specific case.
Tumour-Germline Integration
Occasionally, results from Somatic Genomic Testing hint at something beyond the tumour itself, an underlying inherited predisposition. Your specialist recognises these signals and ensures you and your family receive appropriate guidance should further investigation be warranted.
Contextual, Clinically-Relevant Interpretation
Molecular findings are only meaningful when considered alongside your specific tumour type, stage, and treatment history. Every result is interpreted within this fuller clinical context, ensuring the guidance you receive is accurate and genuinely applicable to your situation, not simply a generic reading of raw data.
Together, these elements ensure that Somatic Genomic Testing delivers far more than a laboratory report — it delivers a clear, actionable path forward for your treatment.
Why Choose London Genetics?
When facing decisions as significant as cancer treatment, choosing the right specialist matters enormously. London Genetics offers Somatic Genomic Testing built around genuine expertise, close clinical collaboration, and access to the latest global research.
Expert-Led Care (Dr. Ehsan Karimiani)
Consultations are led by Dr. Ehsan Karimiani, a GMC-registered clinical geneticist with extensive research and clinical experience in oncology and precision medicine.
Genuine Specialist Interpretation at Every Stage
You're guided by a genuine specialist at every stage, ensuring your results are interpreted with real clinical expertise, not simply generated by a laboratory algorithm.
Clinical & Laboratory Collaboration
We work directly with oncologists and pathologists to ensure your Somatic Genomic Testing results are considered alongside your real-world clinical picture, tumour type, and treatment history, offering a genuinely holistic view that laboratory data alone cannot provide.
Global Research Integration
Our clinical network allows us to connect your results with international research and clinical trial opportunities, ensuring you have access to the latest therapeutic developments, not just what's routinely available through standard local pathways.
Strategic Advantages of Personalised Oncology Care
The shift from conventional oncology to a precision-based approach offers more than just data—it offers a strategic roadmap for survival and quality of life. By choosing somatic genomic testing at London Genetics, patients gain access to a higher tier of Personalised Genetics Services.
Targeted Therapy Selection
The most immediate advantage is the ability to match a patient with the most effective treatment. Traditional “one-size-fits-all” chemotherapy often lacks the specificity needed for complex cases. Through Targeted Cancer Therapy, we identify drugs that specifically attack the cancer’s molecular weaknesses while sparing healthy cells.
Reducing Treatment Toxicity
Understanding your genetic response to medication is crucial. By integrating Oncology Pharmacogenomics, we can predict which treatments might cause severe adverse reactions. This proactive approach to Genetic Wellness ensures that the treatment is not only effective but also tolerable for the patient.
Access to Global Clinical Trials
For many advanced or rare cancers, the best treatment may still be in clinical trials. Our somatic genomic testing identifies rare molecular markers that can qualify patients for Genetic Medicine Programs and international trials at top-tier institutions in London and beyond.
How the Process Works
Somatic Genomic Testing at London Genetics follows a clear, structured pathway, ensuring every stage, from sample to results, is handled with genuine clinical precision.
Hover over each box to see how your sample becomes a clear treatment strategy!
From sample collection through to a fully interpreted result, every stage of Somatic Genomic Testing is designed to move you steadily from raw data towards a genuinely informed treatment strategy.
Distinguishing Somatic Mutations from Germline Predisposition
A critical and often overlooked aspect of somatic genomic testing is the potential to uncover inherited risks. While the primary goal of tumour sequencing is to guide immediate treatment, certain molecular findings can act as a “red flag” for an underlying genetic susceptibility that affects not just the patient, but their entire family.
Understanding the Difference
It is essential for patients to understand the two types of genetic findings that can emerge during somatic genomic testing:
Somatic Mutations: These are acquired changes found only within the tumour cells. They are the main target of Targeted Cancer Therapy and are not passed on to children.
Germline Predisposition: These are inherited mutations present in every cell of the body. If somatic genomic testing suggests a germline origin, it may indicate a hereditary syndrome such as BRCA-related breast cancer or Lynch syndrome.
Why Specialist Recognition is Life-Saving
Only a specialist Clinical Geneticist can accurately recognise when a tumour result suggests a hereditary link. At London Genetics, we provide a seamless transition from tumour analysis to Cancer Genetic Counselling, ensuring that:
Familial Risks are Identified: If a germline mutation is suspected, we guide you through Family Genetic Counselling.
Appropriate Testing is Ordered: We distinguish whether the mutation requires further Hereditary Disease Testing.
Comprehensive Prevention: We help families implement Preventive Genetic Risk Screening to stop cancer before it starts.
What You Can Expect
-
A Clear Molecular Understanding of Your Tumour: You'll know exactly which genetic alterations are driving your specific cancer, rather than working from generalised assumptions.
-
Guidance on Targeted Treatment Options: Where relevant, actionable mutations are identified alongside the corresponding targeted therapies, helping move away from a one-size-fits-all approach.
-
Clarity on Uncertain Findings and Hereditary Risk: Any Variants of Uncertain Significance are properly assessed and explained in context, and where results suggest an underlying inherited predisposition, you'll be guided towards appropriate further testing and genetic counselling for you and your family.
-
A Genuinely Informed Treatment Strategy: Your results are translated into clear, clinically relevant guidance your oncology team can act on directly, rather than raw data requiring further interpretation.
Conclusion: The Future of Precision Oncology
Somatic genomic testing is a cornerstone of modern oncology, offering a path from generalized cancer care to highly targeted, evidence-based treatments. By uncovering the unique molecular alterations within a tumour, this testing empowers clinicians to select therapies that are most likely to succeed, significantly improving clinical outcomes and patient quality of life.
Translating Data into Clinical Action
The true value of somatic genomic testing lies not just in the sequencing itself, but in the expert interpretation of the data. Navigating the complexities of molecular oncology—from identifying actionable variants to distinguishing inherited risks—requires specialized clinical oversight to ensure safety and accuracy in treatment decisions.
At London Genetics, we bridge the gap between advanced laboratory reports and real-world medical practice, providing families and multidisciplinary teams with the clarity needed to make informed, life-changing decisions in the fight against cancer.
Take the next step towards precision oncology. Book a specialist consultation with Dr. Ehsan Ghayoor Karimiani at London Genetics to discuss how somatic genomic testing can guide your personalized treatment journey.
Book a ConsultationIn this section you can check frequently asked questions.
What is the difference between Somatic and Germline testing?
Somatic genomic testing looks for mutations that occur only in cancer cells (acquired during a person’s life), which helps in choosing cancer drugs. Germline testing looks for inherited mutations present in every cell of the body, which determines hereditary cancer risks for you and your family.
How can somatic testing help in choosing a cancer treatment?
By identifying specific molecular markers, somatic genomic testing allows oncologists to match the patient with Targeted Cancer Therapy. This avoids the “trial and error” approach and helps select medications that are most likely to be effective for your specific tumour’s genetic makeup.
Can somatic testing determine if my cancer is hereditary?
While the primary focus is the tumour, somatic genomic testing can sometimes reveal high-frequency mutations that strongly suggest an underlying Hereditary Disease. In such cases, a specialist interpretation is vital to decide if further family screening is required.
What does it mean if my report shows a "Variant of Uncertain Significance" (VUS)?
A VUS means a genetic change was found, but its impact on cancer growth is not yet fully understood. At London Genetics, we provide Specialist Result Interpretation to cross-reference these findings with the latest global research databases.
Do I need a referral for Somatic Genomic Testing in London?
While we work closely with your oncologist, you can book a Genomics Consulting session directly with Dr. Karimiani to review your eligibility for testing or to get a second opinion on an existing genomic report.
